Argentum nitricum 6c homeopathic tablets
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Homeopathic argentum nitricum
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 6 · Randomised trials: 2 · 1980–2026
Showing the 50 most relevant studies, sorted by most relevant.
van Haselen R, Loef M, Dua P, et al.
2026
- Complementary Therapies
- Homeopathy
- Evidence-Based Medicine
BackgroundEvidence synthesis for whole medical systems, defined as complete systems of theory and practice that have evolved independently from biomedicine. is challenging. This paper provides a framework for evidence synthesis of Traditional, Complementary and Integrative Medicine (TCIM) systems incorporating context and complexity. A systematic review program on the effects of homeopathic preparations is used as a practical illustration of the proposed framework.Proposed solutionA systems perspective considers the patient as a complex system of interconnected regulative subsystems embedded in a complex environment, and disease as a dysregulation of the dynamic adaptive state of the organism. Most TCIM systems, including homeopathy, aim to stimulate regulative systems and their functions to regain homeostasis. The consequences of these principles for the approach to evidence synthesis of TCIM systems are explored and explained.Framework componentsA systems perspective takes into account a plurality of evidence sources, including 'real-world' clinical data such as case reports, case series and cohort studies. The systematic review program focuses on comparative studies of homeopathy in various clinical indications and includes both non-randomized prospective studies of interventions (NRSIs) and randomized controlled trials (RCTs). For risk-of-bias assessments, use is made of respectively ROBINS-I and ROB2. Evidence certainty is graded transparently and rigorously based on the GRADE framework. An experienced patient advocate is involved in the research program and input from patient advisors who experienced the clinical indication under investigation is incorporated.DiscussionRCT and NRSI evidence on homeopathic preparations for a range of clinical indications will be synthesised. A limitation, from a complex systems perspective, is that the implication of these findings will still need to be contextualized within the broader context of the existing state of knowledge. An 'evidence eco-system' that includes complementary sources of information will be required to inform decisions.ConclusionEvidence synthesis of TCIM systems can move beyond conventional approaches by framing evidence within its complexity and context, together with real-world data and patient perspectives. This approach entails methodological challenges and will require gap analyses to guide future research and improve the applicability for public health and individualized patient care.
Abstract licence: CC BY
Tournier A, Klein SD, Würtenberger S, et al.
2019
- Materia Medica
- Homeopathy
- Bibliometrics
Objectives: In Part 1 of the review of physicochemical research performed on homeopathic preparations the authors identified relevant publications of sufficient reporting quality for further in-depth analysis. In this article, the authors analyze these publications to identify any empirical evidence for specific physicochemical properties of homeopathic preparations and to identify most promising experimental techniques for future studies. Methods: After an update of the literature search up to 2018, the authors analyzed all publications in terms of individual experiments. They extracted information regarding methodological criteria such as blinding, randomization, statistics, controls, sample preparation, and replications, as well as regarding experimental design and measurement methods applied. Scores were developed to identify experimental techniques with most reliable outcomes. Results: The publications analyzed described 203 experiments. Less than 25% used blinding and/or randomization, and about one third used adequate controls to identify specific effects of homeopathic preparations. The most promising techniques used so far are nuclear magnetic resonance (NMR) relaxation, optical spectroscopy, and electrical impedance measurements. In these three areas, several sets of replicated high-quality experiments provide evidence for specific physicochemical properties of homeopathic preparations. Conclusions: The authors uncovered a number of promising experimental techniques that warrant replication to assess the reported physicochemical properties of homeopathic preparations compared with controls. They further discuss a range of experimental aspects that highlight the many factors that need to be taken into consideration when performing basic research into homeopathic potentization. For future experiments, the authors generally recommend using succussed (vigorously shaken) controls, or comparing different homeopathic preparations with each other to reliably identify any specific physicochemical properties.
Abstract licence: CC BY
Nag U, Pal RK, Saha S, et al.
2024
- Menstruation Disturbances
- Materia Medica
- Homeopathy
Ankit Saha, S. M. Alam, R. Pal, et al.
Journal of integrative and complementary medicine, 2026
C. Raak, A. Büssing, T. Ostermann
2009
Abhishek Kumar
Bhartiya Krishi Anusandhan Patrika, 2025
Homeopathy has been increasingly investigated as a complementary approach in the management of reproductive disorders in livestock. Several studies in dairy cattle and buffaloes have demonstrated the efficacy of homeopathic complexes, administered in various potencies (e.g., 30C, 200C, 6C, 30X and MK), in managing conditions such as true anoestrus, ovarian inactivity, cystic ovarian disease, postpartum anestrus and endometritis. These remedies, including Calcarea phosphorica, Sepia, Pulsatilla, Aletris farinosa and Oophorinum, appear to exert regulatory effects on the hypothalamic-pituitary-gonadal (HPG) axis, improving ovarian cyclicity, estrus induction and conception rates. Additionally, some homeopathic formulations have shown potential in modulating mineral metabolism, supporting follicular development and restoring hormonal balance. Beyond female fertility, emerging evidence highlights the potential role of homeopathy in enhancing male fertility by improving mitochondrial bioenergetics, sperm motility and semen quality. Complexes such as Ubichinon compositum®, Coenzyme compositum® and individualized remedies like Sulphur, Phosphorus, Lycopodium, Argentum nitricum and Pulsatilla have demonstrated promising effects on sperm function and cryopreservation outcomes in bulls. Collectively, these findings suggest that homeopathy, through endocrine modulation, metabolic support and cellular bioenergetics enhancement, holds promise as a safe and viable alternative or adjunct therapy for improving reproductive performance in farm animals.
Abstract licence: CC BY
P. Bellavite, P. Magnani, M. Marzotto, et al.
Homeopathy, 2009
- Homeopathy
- Mice
- Gelsemium
M. Van Wassenhoven, M. Goyens, Pierre Dorfman, et al.
Homeopathy, 2024
M. Wassenhoven, M. Goyens, Pierre Dorfman, et al.
International Journal of High Dilution Research - ISSN 1982-6206, 2025
Background and Objectives Over the past decade, research using various methods has claimed the material nature of high homeopathic potencies. The current study aims to verify these findings using pH measurements. Methods Six independent serial dilutions of commonly used homeopathic medicines, either soluble (Arnica, Belladona, Gelsemium, Pyrogenium, Pyrogenium crudum, Kalium muriaticum) or insoluble (Cuprum, Argentum, Silicea), and prepared according to European Pharmacopoeia standards were pooled and used for pH measurement. We compared the homeopathic dynamisations (DYNs) in pure water with their potentized controls and with simple dilutions (DILs) up to 30cH/10−60. We also tested the influence of the container (Glass or Polyethylene terephthalate ‘PET’) on the solvent controls. Results The different manufacturing processes of the stocks (trituration required or not) influence the pH results. Stock heating process changes the pH of the entire production line. pH measurements can distinguish a dynamised production line from its dynamised solvent but not always from their simple dilution. The presence of a stock at the beginning of a homeopathic manufacturing process modifies the electrical behaviour of the solvent during all successive dilutions, even at the highest dilutions/dynamisations. The container has a significant effect on the electric field indicating the involvement of the atmosphere and leaching processes. Conclusion In homeopathic potentisations of all stocks, an electric field can be measured with specific intensities, even when diluted beyond Avogadro’s number. Homeopathic potentisation is not a simple solvent dilution. The starting material, the solvent used, the type of container and the manufacturing method influence the characteristics of these electric fields. The process of heating the stock should be avoided. The reasons for the presence of these pH values and their stability are not known, but they are most likely related to the presence of nanometric superstructures in these preparations. The role of pH in the manufacturing process and in the effects of homeopathic medicines should be further investigated.
Abstract licence: CC BY-NC-SA
Quamar Sultana, R. Pal, S. Saha, et al.
Homeopathy, 2025
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.